Michelle_Papka@urmc.rochester.edu

Dr. Papka holds a courtesy appointment as Research Assistant Professor at the Center for Molecular and Behavioral Neuroscience at Rutgers University, and also maintains an Assistant Professor faculty position in the Department of Neurology at the University of Rochester Medical Center. She received her Doctoral degree in Cognitive Psychology from Temple University in 1995. Afterwards, she completed a 2-year Fellowship in the Department of Neurology at the University of Rochester Medical Center. She was then invited to join the Faculty there, and continues to maintain this position from afar. Dr. Papka is trained as both a researcher and a clinician. Her interests lie broadly in aging and memory. She served as the Neuropsychologist for the Alzheimer's Disease Center at the University of Rochester, interfacing her clinical and research expertise. She has received several research grants, including the prestigious Senator Mark Hatfield Award from the National Alzheimer's Association. She recently joined Dr. Mark Gluck's group with the aim of helping to facilitate clinical applications of their ongoing research on the neurobiological substrates of memory. In addition, she is establishing a local private practice to evaluate adults with memory and other cognitive disorders. Additional information about Dr. Papka's professional experience and accomplishments can be found in her CV below.

Website: www.drmichellepapka.com

Curriculum Vitae

EDUCATION

1986-1990 Lafayette College, Psychology, BA (Honors)

1990-1993 Temple University, Psychology, MA

1993-1995 Temple University, Psychology, Ph.D.

2001-Present Psychoanalytic Center of Northern New Jersey

PROFESSIONAL HISTORY

Academic:

1990-1995 Research Associate, Cognitive Neuroscience Laboratory, Temple University

1990-1995 Research Associate, Philadelphia Geriatric Center

1990-1995 Instructor and Teaching Assistant, Department of Psychology, Temple University

1991-1994 Research Associate, Elwyn, Inc., Institute for Individuals with Mental Retardation

1996 Instructor, Rochester's Scholars Program, University of Rochester

1995-1997 Postdoctoral Fellow, Department of Neurology and Alzheimer's Disease Center, University of Rochester School of Medicine and Dentistry

1997-1998 Senior Instructor, Department of Neurology and Alzheimer's Disease Center, University of Rochester School of Medicine and Dentistry

1998-2001 Neuropsychologist, Alzheimer's Disease Center, University of Rochester School of Medicine and Dentistry

2000-2001 Co-Director, Cognitive and Memory Disorders Program Saint Barnabas Institute of Neurology

1998-Present Assistant Professor, Department of Neurology and Alzheimer's Disease Center, University of Rochester School of Medicine and Dentistry

Clinical:

1995-1997 Neuropsychology Fellow, Alzheimer's Disease Center, Department of Neurology, University Neurology Associates of Rochester, University of Rochester School of Medicine and Dentistry; Geriatric Neurology and Psychiatry, Monroe Community Hospital1997-1999 Neuropsychologist, Geriatric Neurology and Psychiatry Clinic, University of Rochester Medical Center, outpatient consultation

1998-1999 Neuropsychologist, Monroe Community Hospital, all inpatient consultation including rehabilitation and nursing home units

1998-1999 Neuropsychologist, Alzheimer's Disease Center, University of Rochester School of Medicine and Dentistry

2000-2001 Neuropsychologist, Saint Barnabas Institute of Neurology

PROFESSIONAL CERTIFICATION

1997 New York State License, Psychology, #013144-1

2000 New Jersey State License, #SI 03813

PROFESSIONAL ASSOCIATIONS

Member, American Psychological Society

Member, American Psychological Association

Member, Education Committee, Rochester Chapter, Alzheimer's Association

Editorial Positions:

Reviewer, Neurology

Reviewer, The American Journal of Geriatric Psychiatry

Reviewer, Neurobiology of Aging

HONORS AND STUDENT GRANT AWARDS

1990 Phi Beta Kappa, Cum Laude, Honors in Psychology, Lafayette College

1991 Biomedical Student Research Grant Award, Temple University

1992 Psychology Graduate Student Research Grant Award, Temple University

1993 Graduate Student Travel Award, Temple University

1998 The Senator Mark Hatfield Award for Clinical Research in Alzheimer's Disease, Alzheimer's Association

1998 Travel Award, 6th International Conference on Alzheimer's Disease

GRANT SUPPORTED RESEARCH ACTIVITIES

1991-1993 Research Associate, Philadelphia Geriatric Center, Biomedical Research Grant, Diana Woodruff-Pak, Principal Investigator.

1990-1995 Research Associate, Alzheimer's Disease and Related Disorders Association, Grant IIRG-91-059, Diana Woodruff-Pak, Ph.D., Principal Investigator.

1990-1995 Research Associate, National Institute of Aging, 1 RO1 09752, Diana Woodruff- Pak, Ph.D., Principal Investigator.

1995-1996 Neuropsychologist, "Effects of Citicoline in ischemic stroke patients," Nordic Merrill-Dow Pharmaceuticals, Curt Benesch, M.D., Principal Investigator.

1995- 1997 Neuropsychologist, "Effects of Estradiol in Female Alzheimer's Disease Patients," Rochester Alzheimer's Disease Center, Pilot Grant, Donna Palumbo, Ph.D., Principal Investigator

1996-1998 Neuropsychologist, "Effects of Donepezil Hydrochloride in the Management of Patients with Alzheimer's Disease in a Nursing Home Facility," Eisai-Pfizer Pharmaceutical Corporation Grant, Pierre Tariot, M.D., Principal Investigator

1995-2001 Co-Investigator, Neurobiology of Aging and Alzheimer's Disease, National Institute of Aging, AG 08665, 10% effort, Paul Coleman, Ph.D., Principal Investigator 1999-2001 Site Principal Investigator, National Institute of Aging, ADC Suppl, 5% effort, Michael Grundman, M.D., Principal Investigator, Total direct costs $100,000.

Current Support:

1998-Present Principal Investigator, National Alzheimer's Association, Senator Mark Hatfield Award, "Improving Diagnosis: Longitudinal neuropsychological assessments and biological markers in patients with typical AD and the Lewy body variant," 35% effort, Total direct costs $204,545.

1998-Present Principle Investigator, Eisai/Pfizer Inc., Independent Medical Study Grant, "A Single Center, Randomized, Double-Blind, Placebo Controlled, Between-Group Parallel Design, Pilot Study of the Tolerability, Safety, and Efficacy of Daily, Oral Doses of Donepezil in Probable Lewy Body Dementia Patients Compared to Alzheimer's Disease Patients", 20% effort, Total direct costs $142,918.

SUPERVISION OF STUDENTS

1992-1995 Graduate and undergraduate students, Cognitive Neuroscience Laboratory, Temple University and Philadelphia Geriatric Center

1995-1996 Graduate and undergraduate students, Brain and Cognitive Sciences, University of Rochester

1997-1998 Undergraduate students, SUNY Geneseo, semester internships

1997-1999 Carolyn Valone, MA, Research Assistant

1999-Present Leslie Reyes, undergraduate student, Neuroscience Program, University of Rochester

1999-Present Karen Bissiri, Ph.D., Postdoctoral Fellow, Department of Neurology, University of Rochester Medical Center

PRESENTATIONS AT NATIONAL, INTERNATIONAL, AND LOCAL MEETINGS

November, 1991 Society for Neuroscience Annual Meeting, New Orleans, LA. Presented "Eyeblink Classical Conditioning and Neuropsychological Tests in Down's Syndrome Adults."

October, 1992 Society for Neuroscience Annual Meeting, Anaheim, CA. Presented "Longitudinal Investigation of Eyeblink Conditioning and Neuropsychological Tests in Down's Syndrome Adults."

August, 1992 American Psychological Association Annual Meeting, Washington D.C. Presented "Eyeblink Classical Conditioning is Sensitive to Alzheimer-Like Neuropathology in Down's Syndrome Adults."

November, 1993 Society for Neuroscience Annual Meeting, Washington D.C. Presented "Eyeblink Conditioning Over Five Consecutive Days in Alzheimer's Disease, Down's Syndrome, and Normal Elderly."

November, 1994 Society for Neuroscience Annual Meeting, Miami, FL. Presented "Eyeblink Classical Conditioning and Time Production in Patients with Cerebellar Damage."

April, 1994 Fifth Cognitive Aging Conference, Atlanta, GA. Presented "How Many Trials Are Needed to Adequately Assess Eyeblink Classical Conditioning Performance in Humans?"

February, 1995 Departments of Anatomy and Neurobiology and Ophthalmology, University of Kentucky Medical Center. Presented "The Utility of Eyeblink Classical Conditioning in Assessing Pathological Aging."

February, 1995 Departments of Neurobiology and Ophthalmology, State University of New York, Stony Brook. Presented "Eyeblink Classical Conditioning: A Model of Normal and Pathological Aging."

November, 1995 Society for Neuroscience Annual Meeting, San Diego, CA. Presented "Selective Disruption of Eyeblink Classical Conditioning by Concurrent Tapping: Evidence for Cerebellar Processing."

December, 1995 Grand Rounds, Department of Neurology, University of Rochester. Presented "The Medial Temporal Lobe Memory System."

November, 1996 Society for Neuroscience Annual Meeting, Washington D.C. Presented "Neuropsychological Test Performance of Patients with Bilateral Medial Temporal Lobe Damage Including Amygdala is Comparable to That of Control Patients."

May, 1997 Grand Rounds, Department of Neurology, University of Rochester. Presented "New Concepts in Cortical Dementia: Diffuse Lewy Body Disease."

July, 1997 The Sixth National Alzheimer's Disease Education Conference, Chicago, IL. Presented "Lewy Body Disease: An Alzheimer-Like Dementia."

September, 1997 Rochester Conference on Health. Successful Aging and the New Millennium, Rochester, NY. Presented "Diagnosing Lewy Body Disease: Accuracy of Clinical Criteria in Detecting Lewy Body Pathology."

February, 1998 American Neuropsychiatric Association, Ninth Annual Meeting. Honolulu, Hawaii. Presented "Diagnosing Lewy Body Disease." July, 1998 6th International Conference on Alzheimer's Disease and Related Disorders, Amsterdam, Netherlands. Presented "Diagnosing Lewy Body Disease: Accuracy of Clinical Criteria in Detecting Lewy Body Pathology."

September, 1998 University of Rochester Medical Center, Amsterdam Reprise, A Panel Discussion of Research Presented at the 6th International Conference on Alzheimer's Disease. Presented "An Update On Lewy Body Disease." September, 1998 Rochester Chapter Alzheimer's Association, Rochester, NY, Presented "An overview of Alzheimer's Disease." September, 1998 Forum '98 Steuben County Office for the Aging, Bath, NY, Presented "Does aging + forgetfulness = Alzheimer's disease?"

November, 1998 Monroe County Geriatric Grand Rounds, Rochester, NY, Presented "Lewy Body Disease: An Emerging Concept of Cortical Dementia."

November, 1998 SUNY Geneseo, Geneseo, NY, Presented "Neuropsychology of Aging."

February, 1999 American Neuropsychiatric Association, Tenth Annual Meeting. New Orleans, Louisianna. Presented "A Prospective Study of Lewy Body Disease."

March, 1999 Brain Awareness Week, Rochester, NY, Presented "Memory: How it Works."

April, 1999 Corning Hospital, Corning NY, Presented "Normal Aging vs. Pathological Aging."

April, 1999 The Phoenix Project, Corning, NY, Presented "Facts about Normal Aging."

February, 2000 American Neuropsychiatric Association, Eleventh Annual Meeting. Fort Meyers, FL, Presented "Differentiating dementia with Lewy bodies from Alzheimer's disease."

November, 2000 Saint Barnabas Medical Center, Livingston, NJ, Presented: "Normal and Pathological Aging: What is the difference?"

PUBLICATIONS

Original Articles:

Papka, M., Simon, E.W., & Woodruff-Pak, D.S. (1994). A one-year longitudinal investigation of eyeblink classical conditioning and neuropsychological tests in adults with Down's syndrome. Aging and Cognition, 1, 89-104.

Woodruff-Pak, D.S., Coffin, J.M., & Papka, M. (1994). A substituted pyrrolidinone, BMY 21502, and classical conditioning of the nictitating membrane response in young and older rabbits. Psychopharmacology, 22, 312-319.

Woodruff-Pak, D.S., Papka, M., & Simon, E.W. (1994). Eyeblink classical conditioning in Down's syndrome, Fragile X syndrome, and normal adults over and under age 35. Neuropsychology, 8, 14-24.

Simon, E.W., Rappaport, D. A., Papka, M., & Woodruff-Pak, D.S. (1995). Fragile X and Down syndrome: Are there syndrome specific cognitive profiles at low IQ levels? Journal of Intellectual Disability Research, 39, 326-330.

Papka, M., Ivry, R., & Woodruff-Pak, D. S. (1995). Selective disruption of eyeblink conditioning by concurrent tapping. NeuroReport, 6, 1493-1497.

Woodruff-Pak, D. S., & Papka, M. (1996). Huntington's disease and eyeblink classical conditioning: Normal learning but abnormal timing. Journal of the International Neuropsychological Society, 2, 223-334.

Woodruff-Pak, D. S., & Papka, M. (1996). Alzheimer's disease and eyeblink conditioning: 750 ms trace vs. 400 ms delay paradigm. Neurobiology of Aging, 17, 397-404.

Woodruff-Pak, D. S., Papka, M., & Ivry, R. (1996).Cerebellar involvement in eyeblink classical conditioning in humans. Neuropsychology, 10, 443-458.

Papka, M., & Woodruff-Pak, D. S. (1996). Number of trials needed to assess human eyeblink classical conditioning. Psychology and Aging, 11, 373-376.

Woodruff-Pak, D. S., Papka, M., Romano, S., & Li, Y.-T. (1996). Eyeblink classical conditioning in Alzheimer's disease and cerebrovascular dementia. Neurobiology of Aging, 17, 505-512.

Woodruff-Pak, D. S., Romano, S. J., & Papka, M. (1996). Training to criterion in eyeblink classical conditioning in Alzheimer's disease, Down's syndrome with Alzheimer's disease and normal age-matched elderly. Behavioral Neuroscience, 110, 22-29.

Papka, M., Ivry, R., & Woodruff-Pak, D. S. (1997). Eyeblink classical conditioning and awareness revisited. Psychological Science, 8, 404-408.

Papka, M., Rubio, A., & Schiffer, R. B. (1998). A review of Lewy body disease: An emerging concept of cortical dementia. The Journal of Neuropsychiatry and Clinical Neurosciences, 10, 267-279.

Papka, M., Rubio, A., Schiffer, R.B., & Cox, C. (1998). Lewy body disease: Can we diagnose it? The Journal of Neuropsychiatry and Clinical Neurosciences, 10, 405-412.

Kurlan, R., Richard, I., Papka, M., & Marshall, F. (2000). Movement disorders in Alzheimer's disease: more rigidity of definitions needed. Movement Disorders, 15(1), 24-29.

Richard, I., Papka, M., Rubio, A., & Kurlan, R. (2001). Parkinson's disease and dementia with Lewy bodies: One disease or two? Movement Disorders.

Book Chapters:

Woodruff-Pak, D.S., & Papka, M. (1998). Theories of neuropsychology and aging. Invited chapter in V.L. Bengtson, J.E. Ruth, & K.W. Schaie (Eds.), Handbook of Theories of Aging. New York: Springer.
Grundman, M., et al. (2001).

The Alzheimer's Disease Centers' neuropsychological database initiative: A resource for Alzheimer's disease prevention trials. K. Iqbal, S.S. Sisodia, & B. Winblad (Eds.), Alzheimer's Disease: Advances in Etiology Pathogenesis and Therapeutics. New York: John Wiley & Sons, Ltd.

Submitted Manuscripts:

Solomon, G., Papka, M., & McCaffrey, R. (2001). Can brief odor identification testing differentiate clinically diagnosed Alzheimer's disease from dementia with Lewy bodies? An initial investigation. Manuscript submitted for publication.Abstracts (past 3 years):

Papka, M., Schiffer, R., & Rubio, A. (1998). Lewy body disease: Can we diagnose it? The Journal of Neuropsychiatry and Clinical Neurosciences, 9, 695-696.

Papka, M., Schiffer, R., & Rubio, A. (1998). Diagnosing Lewy body disease: Accuracy of clinical criteria in detecting Lewy body pathology. Neurobiology of Aging, 19, S203.

Papka, M., Schiffer, R., & Valone, C. (1999). A prospective study of Lewy body disease. Journal of Neuropsychiatry and Clinical Neurosciences, 11, 141-142.

Papka, M., Valone, C., Hogarth, P. (2000). Differentiating dementia with Lewy bodies from Alzheimer's disease. Journal of Neuropsychiatry and Clinical Neurosciences, 12(1), 134.

Papka, M., Kurlan, R., & Justus, A. (2000). Differentiatiing dementia with Lewy bodies from Alzheimer's disease and Parkinson's disease: Potential for the Cambridge Neuropsychological Test Automated Batteries. Neurobiology of Aging, 21, s216.